Clinical Trial Update: Phase 3 Study of QLG2198 in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus [Phase 3]

View source ↗

Summary

Phase 3 trial of QLG2198 in Chinese adults on haemodialysis with moderate-to-severe pruritus is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uremic Pruritus

Drugs mentioned

• QLG2198

Snippet

Sponsor: Qilu Pharmaceutical (Hainan) Co., Ltd. | Conditions: Uremic Pruritus | Phase 3 | Status: RECRUITING